Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Pfizer slams UK drug pricing plan

BioIndustry Association 
also challenges revision to PPRS

- PMLiVE

Profits down at Lundbeck as revenues slip

Company still feeling effects of Lexapro patent loss

- PMLiVE

EMA on track with biosimilars guidance says industry

Updates expected to build confidence among healthcare professionals and patients

- PMLiVE

Pegasus recruits corporate services lead

Health comms agency announces new business

Profil Institute appoints former Amylin CEO

Dan Bradbury joins board of diabetes company

- PMLiVE

Psoriasis care falling short says Janssen survey

Claims dermatologists in UK are failing to refer to recommended clinical guidelines

UK flag

NHS medicine spend to remain flat for two years

But UK drug pricing deal stops short of PPRS overhaul to value-based system

- PMLiVE

Endo agrees $1.6bn deal to buy Paladin Labs

Gives company access to Canada and emerging markets

- PMLiVE

Novartis debates future of Horsham site

UK research centre could close

Former Pfizer VP joins Antares

Bruce Freundlich appointed senior VP, medical

- PMLiVE

UCB files Vimpat for expanded epilepsy use

Submits monotherapy application to FDA


- PMLiVE

Innovative care partnerships

How forward-thinking service commissioners are tackling the need to provide a cost-efficient health service for an increasingly ageing and demanding population

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links